Nitric Oxide pp 169-185 | Cite as

Characterization of Nitric Oxide Delivery Systems Produced By Various Nanotechnologies

  • Chi H. LeeEmail author
Part of the Methods in Molecular Biology book series (MIMB, volume 704)


Advanced formulations having the capability of long-term protection and preserving the integrity of the nitric oxide molecule were developed for the efficient delivery of nitric oxide. The methods for the production and delivery of nitric oxide produced from diethylenetriamine diazeniumdiolate or S-nitrosoglutathione as a nitric oxide donor to desired target sites in a controlled and sustained release manner are described. The pharmacological assessments of advanced formulations using in vitro and in vivo tests are also described in detail. These systems can be used for the treatment of cardiovascular diseases and sexual dysfunctions.

Key words

Nitric oxide delivery PLGA microparticle polymeric GSNO film cell cytotoxicity blood flow 



This work was partly supported with a grant from the Missouri Life Science Research Board (09-1117). The author would like to thank Dr. Jin-Wook Yoo for his contribution to the formulation development and evaluation processes and Dr. Peter Smith in KUMC for lending us the laser Doppler.


  1. 1.
    Naseem, K. M. (2005) The role of nitric oxide in cardiovascular diseases. Mol Aspects Med 26, 33–65.PubMedCrossRefGoogle Scholar
  2. 2.
    Traub, O., Vanbibber, R. (1995) Role of nitric-oxide in insulin-dependent diabetes-mellitus related vascular complications. West J Med 162, 439–445.PubMedGoogle Scholar
  3. 3.
    Uckert, S., Ehlers, V., Nuser, V., Oelke, M., Kauffels, W., et al. (2005) In vitro functional responses of isolated human vaginal tissue to selective phosphodiesterase inhibitors. World J Urol 23, 398–404.PubMedCrossRefGoogle Scholar
  4. 4.
    Kim, S. W., Jeong, S. J., Munarriz, R., Kim, N. N., Goldstein, I., Traish, A. M. (2003) Role of the nitric oxide-cyclic GMP pathway in regulation of vaginal blood flow. Int J Impot Res 15, 355–361.PubMedCrossRefGoogle Scholar
  5. 5.
    Ignarro, L. (2000) Nitric Oxide: Biology and Pathobiology. Academic, San Diego, IL.Google Scholar
  6. 6.
    Ferrara, D., Zaslau, S. (2007) Success of sildenafil treatment in neurogenic female sexual dysfunction caused by L5-S1 intervertebral disk rupture: a case report. Int J Urol 14, 566–567.PubMedCrossRefGoogle Scholar
  7. 7.
    Yoo, J. W., Lee, J. S., Lee, C. H., Lee, C. H. (2010) Characterization of nitric oxide-releasing microparticles for mucosal delivery. J Biomed Mat Res 92, 1233–1243.Google Scholar
  8. 8.
    Yoo, J. W., Acharya, G., Lee, C. H. (2009) In vivo evaluation of vaginal films for mucosal delivery of nitric oxide. Biomaterials 30, 3978–3985.PubMedCrossRefGoogle Scholar
  9. 9.
    Yoo, J. W., Choe, E. S., Ahn, S. M., Lee, C. H. (2010) Pharmacological activity and protein phosphorylation caused by nitric oxide-releasing microparticles. Biomaterial 31, 552–558.CrossRefGoogle Scholar
  10. 10.
    Hrabie, J., Klose, J., Wink, D., Keefer, L. (1993) New nitric oxide-releasing zwitterions derived from polyamines. J Org Chem 58, 1472–1476.CrossRefGoogle Scholar
  11. 11.
    Pacher, P., Mabley, J. G., Liaudet, L., Evgenov, O. V., Southan, G. J., Abdelkarim, G. E., et al. (2003) Topical administration of a novel nitric oxide donor, linear polyethylenimine-nitric oxide/nucleophile adduct (DS1), selectively increases vaginal blood flow in anesthetized rats. Int J Impot Res 15, 461–464.PubMedCrossRefGoogle Scholar
  12. 12.
    Bilati, U., Allemann, E., Doelker, E. (2005) Poly(D,L-lactide-co-glycolide) protein-loaded nanoparticles prepared by the double emulsion method – processing and formulation issues for enhanced entrapment efficiency. J Microencapsul 22, 205–214.PubMedCrossRefGoogle Scholar
  13. 13.
    Dubernet, C. (1995) Thermoanalysis of microspheres. Thermochim Acta 248, 259–269.CrossRefGoogle Scholar
  14. 14.
    Arcoleo, V., Liveri, V. T. (1996) AFM investigation of gold nanoparticles synthesized in water/AOT/n-heptane microemulsions. Chem Phy Let 258, 223–227.CrossRefGoogle Scholar
  15. 15.
    Pauwels, R., Balzarini, J., Baba, M., Snoeck, R., Schols, D., Herdewijn, P., et al. (1988) Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J Virol Methods 20, 309–321.PubMedCrossRefGoogle Scholar
  16. 16.
    Dubernet, C. (1995) Thermoanalysis of microspheres. Thermochim Acta 248, 259–269.CrossRefGoogle Scholar
  17. 17.
    Berridge, M. V., Tan, A. S. (1993) Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch Biochem Biophys 303, 474–482.PubMedCrossRefGoogle Scholar
  18. 18.
    Treisman, R. (1996) Regulation of transcription by MAP kinase cascades. Curr Opin Cell Biol 8, 205–215.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.School of Pharmacy, University of MissouriKansas CityUSA

Personalised recommendations